{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:41:28Z","timestamp":1793572888237,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-LL-18-4"],"award-info":[{"award-number":["S-LL-18-4"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-LL-18-4"],"award-info":[{"award-number":["S-LL-18-4"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-LL-18-4"],"award-info":[{"award-number":["S-LL-18-4"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-LL-18-4"],"award-info":[{"award-number":["S-LL-18-4"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/27\/L\/NZ6\/03279"],"award-info":[{"award-number":["2017\/27\/L\/NZ6\/03279"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-024-00741-z","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:02:17Z","timestamp":1724860937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Detection of multidrug-resistance in Mycobacterium tuberculosis by phenotype- and molecular-based assays"],"prefix":"10.1186","volume":"23","author":[{"given":"Laima","family":"Vasiliauskait\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Baku\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"Vasiliauskien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Bakonyt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Decewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Dziurzy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Proboszcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita Valerija","family":"Davidavi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birut\u0117","family":"Nak\u010derien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Krenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ka\u010dergius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petras","family":"Stak\u0117nas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Jagielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"741_CR1","volume-title":"Tuberculosis surveillance and monitoring in Europe 2023\u20132021 data","author":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe","year":"2023","unstructured":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2023\u20132021 data. Stockholm: European Centre for Disease Prevention and Control and Copenhagen: WHO Regional Office for Europe. 2023."},{"key":"741_CR2","volume-title":"Module 3: diagnosis - rapid diagnostics for tuberculosis detection, 2021 update","author":"WHO consolidated guidelines on tuberculosis","year":"2021","unstructured":"WHO consolidated guidelines on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0IGO."},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","volume":"4","author":"LJ Pankhurst","year":"2016","unstructured":"Pankhurst LJ, del Ojo Elias C, Votintseva AA, Walker TM, Cole K, Davies J, et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med. 2016;4:49\u201358.","journal-title":"Lancet Respir Med"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/17843286.2021.1999588","volume":"77","author":"K Soetaert","year":"2021","unstructured":"Soetaert K, Ceyssens PJ, Boarbi S, Bogaerts B, Delcourt T, Vanneste K, et al. Retrospective evaluation of routine whole genome sequencing of Mycobacterium tuberculosis at the Belgian National Reference Center, 2019. Acta Clin Belgica: Int J Clin Lab Med. 2021;77:853\u201360.","journal-title":"Acta Clin Belgica: Int J Clin Lab Med"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","volume":"3","author":"TM Walker","year":"2022","unstructured":"Walker TM, Fowler PW, Knaggs J, Hunt M, Peto TE, Walker AS, et al. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis. Lancet Microbe. 2022;3:e265\u201373.","journal-title":"Lancet Microbe"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"11826","DOI":"10.1038\/s41598-019-48401-z","volume":"9","author":"G Torrea","year":"2019","unstructured":"Torrea G, Ng KCS, Van Deun A, Andr\u00e9 E, Kaisergruber J, Ssengooba W, et al. Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Sci Rep. 2019;9:11826.","journal-title":"Sci Rep"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"e01550","DOI":"10.1128\/AAC.01550-17","volume":"62","author":"J Heyckendorf","year":"2018","unstructured":"Heyckendorf J, Andres S, K\u00f6ser CU, Olaru ID, Sch\u00f6n T, Stureg\u00e5rd E. Et. Al. What is resistance? Impact of phenotypic versus molecular Drug Resistance Testing on Therapy for Multi-and extensively drug-resistant tuberculosis. Antimicrob Agents Chemother. 2018;62:e01550\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"741_CR8","doi-asserted-by":"crossref","unstructured":"Fitzgibbon MM, Roycroft E, Sheehan G, Mc Laughlin A-M, Quintyne KI, Brabazon E et al. False detection of rifampicin resistance using Xpert\u00ae MTB\/RIF Ultra assay due to an A451V mutation in Mycobacterium tuberculosis. JAC Antimicrob Resist 2021;3.","DOI":"10.1093\/jacamr\/dlab101"},{"key":"741_CR9","doi-asserted-by":"crossref","unstructured":"Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J et al. The New Xpert MTB\/RIF Ultra: improving detection of Mycobacterium tuberculosis and Resistance to Rifampin in an assay suitable for point-of-care testing. MBio 2017;8.","DOI":"10.1128\/mBio.00812-17"},{"key":"741_CR10","doi-asserted-by":"crossref","unstructured":"Beckert P, Sanchez-Padilla E, Merker M, Dreyer V, Kohl TA, Utpatel C et al. MDR M. Tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era. Genome Med 2020;12.","DOI":"10.1186\/s13073-020-00793-8"},{"key":"741_CR11","first-page":"e02328","volume":"59","author":"CU K\u00f6ser","year":"2021","unstructured":"K\u00f6ser CU, Georghiou SB, Sch\u00f6n T, Salfinger M. On the consequences of poorly defined breakpoints for Rifampin susceptibility testing of Mycobacterium tuberculosis Complex. J Cin Microbiol. 2021;59:e02328\u201320.","journal-title":"J Cin Microbiol"},{"key":"741_CR12","unstructured":"Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine). Geneva: World Health Organization. 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"741_CR13","doi-asserted-by":"publisher","first-page":"e0208721","DOI":"10.1128\/spectrum.02087-21","volume":"10","author":"W Wang","year":"2022","unstructured":"Wang W, Liu R, Yao C, Huo F, Shang Y, Zhang X. Et. Al. Reevaluating rifampicin breakpoint concentrations for Mycobacterium tuberculosis isolates with disputed rpoB mutations and discordant susceptibility phenotypes. Microb Spectr. 2022;10(1):e0208721.","journal-title":"Microb Spectr"},{"key":"741_CR14","doi-asserted-by":"crossref","unstructured":"Sonnenkalb L, Strohe G, Dreyer V, Andres S, Hillemann D, Maurer FP et al. Microevolution of mycobacterium tuberculosis subpopulations and heteroresistance in a patient receiving 27 years of tuberculosis treatment in Germany. Antimicrob Agents Chemother 2021;65.","DOI":"10.1128\/AAC.02520-20"},{"key":"741_CR15","doi-asserted-by":"publisher","first-page":"e01093","DOI":"10.1128\/AAC.01093-18","volume":"62","author":"T Jagielski","year":"2018","unstructured":"Jagielski T, Baku\u0142a Z, Brzostek A, Minias A, Stachowiak R, Kalita J. Et. Al. Characterization of mutations conferring resistance to Rifampin in Mycobacterium tuberculosis clinical strains. Antimicrob Agents Chemother. 2018;62:e01093\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"e02919","DOI":"10.1128\/JCM.02919-20","volume":"60","author":"K Kaniga","year":"2022","unstructured":"Kaniga K, Hasan R, Jou R, Vasiliauskien\u0117 E, Chuchottaworn C, Ismail N, et al. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-resistant tuberculosis (MDR-TB): a 5-Year prospective in Vitro Surveillance Study of Bedaquiline and other second-line drug susceptibility testing in MDR-TB isolates. J Clin Microbiol. 2022;60:e02919\u201320.","journal-title":"J Clin Microbiol"},{"key":"741_CR17","first-page":"3214","volume":"70","author":"T Jagielski","year":"2015","unstructured":"Jagielski T, Baku\u0142a Z, Roeske K, Kami\u0144ski M, Napi\u00f3rkowska A, Augustynowicz-Kope\u0107 E, et al. Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J Antimicrob Chemother. 2015;70:3214\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"741_CR18","volume-title":"Handbook on Tuberculosis laboratory diagnostic methods in the European Union \u2013 updated 2018","author":"European Centre for Disease Prevention and Control","year":"2018","unstructured":"European Centre for Disease Prevention and Control. Handbook on Tuberculosis laboratory diagnostic methods in the European Union \u2013 updated 2018. Stockholm: ECDC; 2018."},{"key":"741_CR19","unstructured":"Technical manual for. drug susceptibility testing of medicines used in the treatment of tuberculosis. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"741_CR20","unstructured":"CLSI. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 2nd edition. CLSI supplement M24S. Clinical and Laboratory Standards Institute; 2023."},{"key":"741_CR21","volume-title":"-resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians","author":"Line probe assays for detection of drug","year":"2022","unstructured":"Line probe assays for detection of drug. -resistant tuberculosis: interpretation and reporting manual for laboratory staff and clinicians. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"741_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmi.2016.09.006","volume":"23","author":"E Andre","year":"2017","unstructured":"Andre E, Goeminne L, Cabibbe A, Beckert P, Kabamba Mukadi B, Mathys V, et al. Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria. Clin Microbiol Infect. 2017;23:167\u201372.","journal-title":"Clin Microbiol Infect"},{"key":"741_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/jcm.31.2.406-409.1993","volume":"31","author":"JDA Van Embden","year":"1993","unstructured":"Van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406\u20139.","journal-title":"J Clin Microbiol"},{"key":"741_CR24","doi-asserted-by":"crossref","unstructured":"Baku\u0142a Z, Dziurzy\u0144ski M, Decewicz P, Bakonyt\u0117 D, Vasiliauskait\u0117 L, Nak\u010derien\u0117 B et al. Spoligotyping of Mycobacterium tuberculosis \u2013 comparing in vitro and in silico approaches. Infect Genet Evol 2023;115.","DOI":"10.1016\/j.meegid.2023.105508"},{"key":"741_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, et al. Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol. 2019;17:533\u201345.","journal-title":"Nat Rev Microbiol"},{"key":"741_CR26","doi-asserted-by":"publisher","first-page":"e01164","DOI":"10.1128\/AAC.01164-21","volume":"65","author":"R Vargas","year":"2021","unstructured":"Vargas R, Freschi L, Spitaleri A, Tahseen S, Barilar I, Niemann S, et al. Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex. Antimicrob Agents Chemother. 2021;65:e01164\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"741_CR27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","volume":"75","author":"S Kadura","year":"2020","unstructured":"Kadura S, King N, Nakhoul M, Zhu H, Theron G, K\u00f6ser CU, et al. Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. J Antimicrob Chemother. 2020;75:2031\u201343.","journal-title":"J Antimicrob Chemother"},{"key":"741_CR28","doi-asserted-by":"crossref","unstructured":"The CRyPTIC Consortium. Epidemiological cutoff values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. Tuberculosis. Eur Respir J 2022;2200239.","DOI":"10.1183\/13993003.00239-2022"},{"key":"741_CR29","doi-asserted-by":"publisher","first-page":"e01885","DOI":"10.1128\/JCM.01885-20","volume":"59","author":"J Shea","year":"2021","unstructured":"Shea J, Halse TA, Kohlerschmidt D, Lapierre P, Modestil AHA, Kearns CH, et al. Low-level Rifampin Resistance and rpoB mutations in Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility Test Data in New York. J Clin Microbiol. 2021;59:e01885\u201320.","journal-title":"J Clin Microbiol"},{"key":"741_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1128\/AAC.01209-13","volume":"58","author":"J Lee","year":"2014","unstructured":"Lee J, Armstrong DT, Ssengooba W, Park JA, Yu Y, Mumbowa F, et al. Sensititre MYCOTB MIC plate for testing mycobacterium tuberculosis susceptibility to first-and second-line drugs. Antimicrob Agents Chemother. 2014;58:11\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"741_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5588\/ijtld.15.0573","volume":"20","author":"X Yu","year":"2016","unstructured":"Yu X, Ma YF, Jiang GL, Chen ST, Wang GR, Huang HR. Sensititre \u00ae MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. Int J Tuberculosis Lung Disease. 2016;20:329\u201334.","journal-title":"Int J Tuberculosis Lung Disease"},{"key":"741_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.cmi.2020.07.036","volume":"26","author":"T Sch\u00f6n","year":"2020","unstructured":"Sch\u00f6n T, Werngren J, Machado D, Borroni E, Wijkander M, Lina G, et al. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates \u2013 the EUCAST broth microdilution reference method for MIC determination. Clin Microbiol Infect. 2020;26:1488\u201392.","journal-title":"Clin Microbiol Infect"},{"key":"741_CR33","unstructured":"Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosiscomplex. Geneva: World Health Organization; 2022. Licence: CCBY-NC-SA3.0IGO."},{"key":"741_CR34","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3389\/fmicb.2018.02265","volume":"26","author":"H Javed","year":"2018","unstructured":"Javed H, Baku\u0142a Z, Ple\u0144 M, Hashmi HJ, Tahir Z, Jamil N, et al. Evaluation of genotype MTBDRplus and MTBDRsl assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium tuberculosis isolates in Pakistan. Front Microbiol. 2018;26:9:2265.","journal-title":"Front Microbiol"},{"key":"741_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4046\/trd.2020.0039","volume":"83","author":"BK Singh","year":"2020","unstructured":"Singh BK, Sharma R, Kodan P, Soneja M, Jorwal P, Nischal N, et al. Diagnostic evaluation of non-interpretable results associated with rpoB gene in genotype MTBDRplus ver 2.0. Tuberc Respir Dis (Seoul). 2020;83:289\u201394.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"4","key":"741_CR36","doi-asserted-by":"publisher","first-page":"114995","DOI":"10.1016\/j.diagmicrobio.2020.114995","volume":"96","author":"R Singhal","year":"2020","unstructured":"Singhal R, Anthwal D, Kumar G, Sah G, Salfinger M, Choudhury S, et al. Genotypic characterization of \u2018inferred\u2019 rifampin mutations in GenoType MTBDRplus assay and its association with phenotypic susceptibility testing of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis. 2020;96(4):114995.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"741_CR37","volume-title":"Mycobacterium tuberculosis complex and their association with drug resistance","author":"Catalogue of mutations in","year":"2021","unstructured":"Catalogue of mutations in. Mycobacterium tuberculosis complex and their association with drug resistance. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0IGO."},{"key":"741_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tube.2018.03.009","volume":"110","author":"R Macedo","year":"2018","unstructured":"Macedo R, Nunes A, Portugal I, Duarte S, Vieira L, Gomes JP. Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision. Guidance? Tuberculosis. 2018;110:44\u201351.","journal-title":"Guidance? Tuberculosis"},{"key":"741_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-021-00953-4","volume":"13","author":"MI Gr\u00f6schel","year":"2021","unstructured":"Gr\u00f6schel MI, Owens M, Freschi L, Vargas R, Marin MG, Phelan J, et al. GenTB: a user-friendly genome-based predictor for tuberculosis resistance powered by machine learning. Genome Med. 2021;13:1\u201314.","journal-title":"Genome Med"},{"key":"741_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jac\/dkz048","volume":"74","author":"MR Farhat","year":"2019","unstructured":"Farhat MR, Sixsmith J, Calderon R, Hicks ND, Fortune SM, Murray M. Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates. J Antimicrob Chemother. 2019;74:1477\u201383.","journal-title":"J Antimicrob Chemother"},{"key":"741_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00092-19","volume":"63","author":"A Ghodousi","year":"2019","unstructured":"Ghodousi A, Tagliani E, Karunaratne E, Niemann S, Perera J, K\u00f6ser CU, et al. Isoniazid Resistance in Mycobacterium tuberculosis is a heterogeneous phenotype composed of overlapping MIC distributions with different underlying resistance mechanisms. Antimicrob Agents Chemother. 2019;63:10.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00741-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00741-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00741-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:03:30Z","timestamp":1724861010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00741-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00741-z","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical University of Warsaw\u2019s Bioethics Committee and Lithuanian Regional Biomedical Research\u2019s Ethics Committee. The requirement for informed consent from the study subjects was waived by the Medical University of Warsaw\u2019s Bioethics Committee and Lithuanian Regional Biomedical Research\u2019s Ethics Committee since the study sample was collected during routine clinical practices, and all personal data were anonymized prior the study. All experimental protocols and methods were approved by the Medical University of Warsaw\u2019s Bioethics Committee and Lithuanian Regional Biomedical Research\u2019s Ethics Committee. All methods were carried out in accordance with guidelines and regulations of the Medical University of Warsaw, Vilnius University, and Vilnius University Hospital Santaros klinikos.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}